We have recently shown that the mitochondrial ferredoxin Yah1p and the ferredoxin reductase Arh1p are required for Q6 biosynthesis at the C5-hydroxylation step (Figure 1) (Pierrel et al., 2010). We have also demonstrated that para-aminobenzoic acid (pABA) is a precursor of Q6 in yeast (Pierrel et al., 2010). This finding implies that when pABA is used as a precursor, an additional NH2-to-OH conversion in Q6 biosynthesis takes place and we develop genetic approaches to characterize this reaction.

Figure 1: Coenzyme Q biosynthetic pathway in S. cerevisiae.
para-hydroxybenzoate (4-HB) is prenylated by Coq2 and then a total of 3 hydroxylation, 3 methylation and 1 decarboxylation yield Q. We have discovered that para-aminobenzoate (pABA, in blue) is also prenylated by Coq2 and converted into Q. The enzymes that convert prenyl-hydroxybenzoate and prenyl-pABA into Q are likely the same, only an additional deamination-hydroxylatio reaction must occur in the case of prenyl-pABA.
We have proven that Coq6, a proposed flavin-dependent monooxygenase is involved exclusively in one of the three hydroxylation reactions of Q biosynthesis: the C5-hydroxylation (Ozeir et al. 2011). The Q6 biosynthetic defect of mutants deficient for the C5-hydroxylation can be bypassed in S. cerevisiae by adding C5-hydroxylated analogues of 4-HB like vanillic acid or 3,4-dihydroxybenzoic acid (Figure 2). This result opens new perspectives in the treatment of Q deficiencies which, to date, are based on coenzyme Q supplementation. We are now working on the hypothesis that Yah1 and Arh1 could be the in vivo source of electrons to reduce the flavin cofactor in Coq6.

Figure 2: Coq6 is required for the C5-hydroxylation of Q6 biosynthesis but Coq6 deficiency can be bypassed by using analogues of 4-HB.
The pathway leading to Q6 biosynthesis in WT S. cerevisiae cells is shown (above dashed line) with Coq6 implicated together with Yah1 and Arh1 in the C5-hydroxylation, whereas the C1-hydroxylation is catalyzed by an unidentified protein (?). In mutant cells (below dashed line) in which the C5-hydroxylation does not take place (crossed arrow), the C1-decarboxylation (dashed arrow) and the C1-hydroxylation proceed efficiently, leading to the accumulation of 3-hexaprenyl-4-hydroxyphenol (4-HP) when 4-HB is prenylated, or the accumulation of 3-hexaprenyl-4-aminophenol (4-AP) when pABA is prenylated (blue). 3,4-diHB and VA contain an additional C5-hydroxyl (green) or C5-methoxyl (green) and enter the Q6 biosynthetic pathway after prenylation by Coq2, leading to restoration of Q6 biosynthesis in cells deficient for the C5-hydroxylation reaction.

Leader

